36 related articles for article (PubMed ID: 16172331)
1. The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets.
Guglielmo A; Zengarini C; Agostinelli C; Motta G; Sabattini E; Pileri A
Cells; 2024 Mar; 13(7):. PubMed ID: 38607023
[TBL] [Abstract][Full Text] [Related]
2. Macrophage centripetal migration drives spontaneous healing process after spinal cord injury.
Kobayakawa K; Ohkawa Y; Yoshizaki S; Tamaru T; Saito T; Kijima K; Yokota K; Hara M; Kubota K; Matsumoto Y; Harimaya K; Ozato K; Masuda T; Tsuda M; Tamura T; Inoue K; Edgerton VR; Iwamoto Y; Nakashima Y; Okada S
Sci Adv; 2019 May; 5(5):eaav5086. PubMed ID: 31106270
[TBL] [Abstract][Full Text] [Related]
3. Oral retinoids and rexinoids in cutaneous T-cell lymphomas.
Sokołowska-Wojdyło M; Lugowska-Umer H; Maciejewska-Radomska A
Postepy Dermatol Alergol; 2013 Feb; 30(1):19-29. PubMed ID: 24278042
[TBL] [Abstract][Full Text] [Related]
4. Immune modulators as therapeutic agents for cutaneous T-cell lymphoma.
Rook AH; Benoit B; Kim EJ; Vittorio CC; Anshelevich A; Raphael BA; Introcaso CE; Gardner JM; Evans KG; Morrissey K; Samimi S; Musiek AC; Showe LC; Wasik MA; Wysocka M
Clin Lymphoma Myeloma Leuk; 2010 Sep; 10 Suppl 2(0 2):S93-5. PubMed ID: 20826407
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging treatment strategies for cutaneous T-cell lymphoma.
Lansigan F; Foss FM
Drugs; 2010 Feb; 70(3):273-86. PubMed ID: 20166766
[TBL] [Abstract][Full Text] [Related]
6. Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.
Duvic M; Vu J
Biologics; 2007 Dec; 1(4):377-92. PubMed ID: 19707308
[TBL] [Abstract][Full Text] [Related]
7. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM
Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509
[TBL] [Abstract][Full Text] [Related]
8. [New developments in Sézary syndrome].
Caudron A; Marie-Cardine A; Bensussan A; Bagot M
Ann Dermatol Venereol; 2012 Jan; 139(1):31-40. PubMed ID: 22225740
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis in Sézary syndrome.
Russell-Jones R; Fraser-Andrews E; Spittle M; Whittaker S
Lancet; 1997 Sep; 350(9081):886. PubMed ID: 9310623
[No Abstract] [Full Text] [Related]
10. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
11. Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol.
Arulogun S; Prince HM; Gambell P; Lade S; Ryan G; Eaton E; McCormack C
J Am Acad Dermatol; 2008 Oct; 59(4):589-95. PubMed ID: 18656282
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.
Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome.
Tsirigotis P; Pappa V; Papageorgiou S; Kapsimali V; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Stavrianeas N; Economopoulos T; Dervenoulas J
Br J Dermatol; 2007 Jun; 156(6):1379-81. PubMed ID: 17459033
[No Abstract] [Full Text] [Related]
14. The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome.
McGinnis KS; Ubriani R; Newton S; Junkins-Hopkins JM; Vittorio CC; Kim EJ; Wysocka M; Rook AH
Arch Dermatol; 2005 Sep; 141(9):1176-8. PubMed ID: 16172331
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
